Palo Alto Investors LP Gilead Sciences, Inc. Transaction History

Palo Alto Investors LP

  • $856 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $2.46 Million - $3.15 Million
-39,300 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $8.54 Million - $9.43 Million
-136,600 Reduced 77.66%
39,300 $2.49 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $12.7 Million - $15 Million
175,900
175,900 $14.3 Million

Others Institutions Holding GILD

# of Institutions
1,884
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $86B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email